These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 5357395

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical effects of purine metabolism disorders in hematopoietic proliferative diseases].
    Szmigiel Z, Pawlicka G, Sowa M.
    Pol Tyg Lek; 1976 Dec 06; 31(49):2119-22. PubMed ID: 1005192
    [No Abstract] [Full Text] [Related]

  • 23. [Renal involvement in rheumatoid purpura in adults. Study of 20 renal biopsies. Value of the examination of the glomerulus in immunofluorescence].
    Fillastre JP, Morel-Marogér L, Ducroiset B, Richet G.
    Presse Med (1893); 1970 Dec 12; 78(53):2375-8. PubMed ID: 4924757
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Theory of pathogenesis in primary hyperuricamia].
    Mertz DP.
    Med Klin; 1975 Jul 11; 70(28-29):1187-98. PubMed ID: 170496
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ, Prior C, Puig JG.
    Metabolism; 2007 Sep 11; 56(9):1179-86. PubMed ID: 17697859
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Renal disease in primary gout.
    Barlow KA, Beilin LJ.
    Q J Med; 1968 Jan 11; 37(145):79-96. PubMed ID: 5657765
    [No Abstract] [Full Text] [Related]

  • 31. [Various pathophysiological, clinical and therapeutic problems of disorders of purine metabolism].
    Chodorowski Z.
    Pol Tyg Lek; 1982 Oct 25; 37(40):1211-3. PubMed ID: 6761669
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Conservative therapy of chronic renal failure].
    Reubi F.
    Helv Med Acta Suppl; 1969 Oct 25; 49():88-99. PubMed ID: 4192458
    [No Abstract] [Full Text] [Related]

  • 36. A preliminary report of nephropathy in hyperuricemic rats.
    Waisman J, Bluestone R, Klinenberg JR.
    Lab Invest; 1974 Jun 25; 30(6):716-22. PubMed ID: 4835598
    [No Abstract] [Full Text] [Related]

  • 37. Leukemic urate nephropathy.
    Kanwar YS, Manaligod JR.
    Arch Pathol; 1975 Sep 25; 99(9):467-72. PubMed ID: 1057883
    [Abstract] [Full Text] [Related]

  • 38. Uric acid and the kidney.
    Weinman EJ.
    Perspect Nephrol Hypertens; 1976 Sep 25; 3():141-58. PubMed ID: 2900
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical picture of gout and gouty (hyperuricemic) kidney].
    Sosovec V.
    Vnitr Lek; 1975 Aug 25; 21(8):808-12. PubMed ID: 1162915
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
    Günther R, Knapp E.
    Wien Klin Wochenschr; 1969 Nov 07; 81(45):817-20. PubMed ID: 5362152
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.